![]() |
市場調查報告書
商品編碼
1371875
到 2030 年醫療影像影像市場預測:按部署模式、解決方案、技術、影像模式、用途、最終用戶和地區進行的全球分析Artificial Intelligence in Medical Imaging Market Forecasts to 2030 - Global Analysis By Deployment Mode, Solution, Technology (Deep Learning, Natural Language Processing and Other Technologies), Imaging Mode, Application, End User and By Geography |
根據Stratistics MRC預測,2023年全球醫療影像診斷領域人工智慧(AI)市場規模將達到17.7億美元,預測期內年複合成長率為28.5%,到2030年將達到102.5億美元。預計將達到。
醫學影像處理中的人工智慧(AI)是指將人工智慧技術應用於各種顯像模式,例如超音波、電腦斷層掃描(CT)、磁振造影(MRI)和X光,以改善醫學影像的處理. - 指自動化。使用先進的演算法和機器學習模型從醫學影像中分析和提取重要資訊,以幫助識別、診斷和治療各種疾病和狀況。
根據美國癌症協會總合,今年美國將新增 236,740 例肺癌和支氣管癌罹患。
目前的醫學影像處理市場是由人工智慧驅動的。這是因為該軟體的好處是可以讓醫生更快診斷疾病並提供早期療育。此外,新的人工智慧主導新興企業正在專注於人工智慧醫療影像解決方案並添加複雜的功能。推進醫學影像處理領域的人工智慧還需要增加該領域的資金和投資。例如,立陶宛的 oxipit.ai 於 2023 年 1 月籌集了 490 萬美元資金,用於開發完全自主的 AI醫療圖像並拓展新地區的市場。因此,全球人工智慧主導的新興企業數量不斷增加,以及用於開發完全自主的人工智慧醫學影像處理工具的資金籌措不斷增加,正在推動市場成長。
市場成長受到醫學影像樣本和其他診斷多種疾病的設備中使用的各種人工智慧技術成本高昂的限制。目前,低度開發國家和開發中國家的大多數醫院和研究機構無法承擔醫學影像處理人工智慧研究的高額成本。因此,這些要素阻礙了市場的成長。
先進的人工智慧工具和技術預計將在未來年度徹底改變醫療保健和放射行業。目前涉足醫療影像處理產業AI的企業預測,AI在醫療領域尤其是放射科領域的引進,將帶來廣泛的機會。此外,掃描數量的增加與能夠讀取資料的放射科醫生數量之間的差距日益擴大,是促進人工智慧在醫學影像處理市場中採用的一個主要要素。
資料外洩和詐欺存取患者資料可能會阻礙人工智慧在醫學影像行業的普及。對於市場參與企業來說,平衡資料可近性和隱私性是很困難的。此外,使用人工智慧進行醫學影像處理需要遵守法規和法律要求。用於醫療用途的人工智慧演算法的開發和應用必須遵循管理機構和醫療設備主管機關制定的嚴格法規。這些方面都限制了市場的拓展。
COVID-19大流行對全球幾乎所有行業都產生了重大影響,醫療保健除外。醫療保健領域開發人工智慧解決方案的主要領域是醫學影像處理。由於 COVID-19 在感染疾病和肺部疾病影像中的廣泛使用,許多醫院放射科的使用量顯著增加。疫情與對技術和數位解決方案的需求增加之間存在很強的相關性。從中長期來看,COVID-19 技術的影響可能非常正面。
預計 X 光領域在預測期內將佔據最大的市場佔有率。由於其高精度,X光模式對人工智慧的需求不斷增加。 X光影像與AR和VR技術的整合為放射科醫生提供了身臨其境型的互動體驗。醫療保健專業人員現在可以查看3D X 光影像,疊加解剖細節,甚至模擬術前計畫的程序。此外,這些工具有助於更準確的解釋、提高空間理解並加速片段進展。
在預測期內,乳房篩檢領域預計將以最高成長率擴大。乳房篩檢的需求是由於乳癌患者數量不斷增加以及患者希望早期診斷以幫助他們盡快接受適當的治療而推動的。此外,政府支持臨床解讀和擴大乳癌篩檢技術的配合措施是預計推動細分市場擴張的兩個關鍵因素。
由於技術先進的基礎設施和高人均收入,預計北美將在 2022 年佔據市場主導地位,並在預測期內繼續佔據主導地位。醫療影像處理市場中的人工智慧是由該地區眾多市場參與者和有利的政府法規所推動的。該地區的研究和醫療機構也在人工智慧方面進行了大量投資。此外,主要行業參與者的強大影響力和蓬勃發展的醫療基礎設施正在推動該地區的成長。
由於最尖端科技的普及、網路連接的改善以及政府配合措施的增加,預計亞太地區將呈現最高的成長率。投資的急劇增加、越來越多的新興企業使用人工智慧(AI)(尤其是在中國和印度)以及人工智慧透過提高圖像品質來縮小該地區醫療基礎設施差距的巨大潛力都是進一步的推動因素。這些技術還具有很高的臨床價值,推動市場成長。
According to Stratistics MRC, the Global Artificial Intelligence (AI) in Medical Imaging Market is accounted for $1.77 billion in 2023 and is expected to reach $10.25 billion by 2030 growing at a CAGR of 28.5% during the forecast period. Artificial intelligence (AI) in medical imaging refers to the application of AI techniques to a variety of imaging modalities, including ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and X-rays, to improve and automate the processing of medical images. It involves analyzing and extracting significant information from medical images using sophisticated algorithms and machine learning models in order to aid in the recognition, diagnosis, and treatment of a variety of illnesses and ailments.
According to the American Cancer Society, a total of 236,740 new cases of lung and bronchus cancer are estimated this year in the United States.
The market for medical imaging is being driven by AI in the current scenario. This is because the software gives doctors a benefit by making it possible for them to diagnose illnesses much more quickly and enable earlier intervention. Additionally, new AI-driven start-ups are putting an emphasis on and adding sophisticated features to AI medical imaging solutions. To advance AI in medical imaging, it is also necessary to increase funding and investment in the field. For instance, Lithuania's oxipit.ai raised USD 4.9 million in funding in January 2023 to develop fully autonomous AI medical imaging and broaden the market in new regions. Thus, market growth is being driven by the rising number of AI-driven start-ups globally and the rising funding for the development of fully autonomous AI medical imaging tools.
The market's growth is constrained by the high cost of various artificial intelligence techniques used in medical imaging samples and other equipment for diagnosing many diseases. The majority of hospitals and research institutions in underdeveloped and developing nations are currently unable to afford the higher costs associated with the R&D of artificial intelligence in medical imaging. These factors thus inhibit market growth.
In the upcoming years, it is anticipated that advanced AI tools and technology will significantly change the healthcare and radiology industries. Companies involved in the current AI in the medical imaging industry anticipate that the adoption of AI in the medical field, particularly in radiology, will present a wide range of opportunities. Moreover, the growing disparity between the rising number of scans and the number of available radiologists who can read data is a major factor that will aid in the adoption of AI in the medical imaging market.
Data breaches or unauthorized access to patient data could hinder the widespread use of AI in the medical imaging industry. Finding a balance between data accessibility and privacy will be difficult for market participants. Additionally, AI must adhere to rules and legal requirements before it can be used in medical imaging. Strict regulations, such as those set forth by governing bodies and medical device authorities, must be followed in the development and application of AI algorithms for medical applications. Such aspects limit the market from expanding.
The COVID-19 pandemic has had a significant impact on nearly every industry worldwide, with the exception of healthcare. The primary area in the healthcare sector where AI-enabled solutions are being developed is medical imaging. Due to the widespread use of COVID-19 for imaging infectious and lung diseases, radiology has seen a significant increase in use in many hospitals. A strong correlation exists between the pandemic and the increased demand for technology and digital solutions. The impact of COVID-19 technology could be very positive in the medium to long term.
During the forecast period, the X-ray segment is anticipated to hold the largest market share. The demand for AI in X-ray modalities has increased due to its high accuracy. Radiologists can now experience immersive and interactive experiences thanks to the integration of AR and VR technologies with X-ray imaging. X-ray images can now be seen in three dimensions by medical professionals, who can also overlay anatomical details or simulate procedures for preoperative planning. Moreover, these tools can facilitate more accurate interpretations and improve spatial comprehension, which would accelerate segment progression.
It is anticipated that during the forecast period, the breast screening segment will expand at the highest rate. The demand for breast screening is being driven by the increase in breast cancer cases and patients' desires for an early-stage diagnosis, which aids in receiving the proper treatment as soon as possible. Furthermore, government initiatives that support clinical interpretation and expanded access to breast cancer screening technologies are two additional major factors that are anticipated to fuel segment expansion.
Due to the technologically sophisticated infrastructure and high per capita income, North America dominated the market in 2022 and is predicted to dominate over the forecast period. The market for AI in medical imaging is being driven by the presence of numerous market players and favorable government regulations in the area. In addition, the region's research organizations and healthcare institutions are making significant investments in AI. Furthermore, a strong presence of major industry players and a thriving healthcare infrastructure are fostering regional growth in this region.
Due to the widespread adoption of cutting-edge technologies, improved network connectivity, and expanded government initiatives, Asia Pacific is anticipated to experience the highest growth rate. The exponential growth in investment, the rise in artificial intelligence (AI)-using startups, particularly in China and India, and the enormous potential for AI to close the region's healthcare infrastructure gap by enhancing image quality are additional motivating factors. These technologies also have a high clinical value, which is promoting market growth.
Some of the key players in Artificial Intelligence (AI) in Medical Imaging market include: 1QB Information Technology, Agfa-Gevaert Group, Arterys Inc, AZmed, BenevolentAI, BioXcel, Therapeutics Inc, Butterfly Network, Caption Health, CellmatiQ, dentalXrai, Digital Diagnostics, EchoNous, Enlitic, Inc, GE Healthcare, Gleamer, HeartVista, IBM Watson Health, K Health, Koninklijke Philips, mPulse Mobile, Nanox Imaging, OrCam, Owkin Inc., Siemens Healthineers AG, Suki AI, Inc, Ultromics, Viz.ai, Inc, ZealthLife technologies Pte. Ltd and Zebra Medical Vision.
In October 2023, BioXcel Therapeutics, Inc., a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience, today provided an update on recent developments with its late-stage clinical programs as well as its patent portfolio for IGALMI™ (dexmedetomidine) sublingual film. These developments include meetings scheduled with the U.S. Food and Drug Administration (FDA) to discuss the TRANQUILITY and SERENITY III clinical programs and the receipt of two Notices of Allowance (NOAs) from the U.S. Patent and Trademark Office to extend method of use patent protection for sublingual dexmedetomidine.
In August 2023, Butterfly Network, Inc. a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, announced the release of its software development kit (SDK) for use by third parties. The kit will allow developers to utilize Butterfly's platform to build custom applications that can be commercialized to Butterfly's customer base - the largest user network in handheld point-of-care ultrasound.1 The Company ultimately plans to open "Butterfly Garden," an AI Marketplace where new apps will be hosted for Butterfly users to discover and purchase the latest AI capabilities.
In April 2023, AGFA HealthCare, a leading provider of Enterprise Imaging solutions, is proud to announce that it has joined the Amazon Web Services (AWS) Partner Network (APN) to scale up the global availability of AGFA Enterprise Imaging (AGFA EI) VNA and XERO® Universal Viewer on the cloud. The APN is a global community of AWS Partners that leverage programs, expertise, and resources to build, market, and sell customer offerings.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.